Cargando…

Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls

Due to the worldwide COVID-19 outbreak it is mandatory for health care workers to develop containment strategies. Recently published data showed, that cancer patients might have a higher risk for severe course of the disease. We therefore developed a strategy of screening and containment for SARS-Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaddu-Mulindwa, Dominic, Thurner, Lorenz, Bewarder, Moritz, Murawski, Niels, Ahlgrimm, Manfred, Pfuhl, Thorsten, Gärtner, Barbara, Smola, Sigrun, Stilgenbauer, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903402/
https://www.ncbi.nlm.nih.gov/pubmed/33627114
http://dx.doi.org/10.1186/s13027-021-00356-5
_version_ 1783654730163027968
author Kaddu-Mulindwa, Dominic
Thurner, Lorenz
Bewarder, Moritz
Murawski, Niels
Ahlgrimm, Manfred
Pfuhl, Thorsten
Gärtner, Barbara
Smola, Sigrun
Stilgenbauer, Stephan
author_facet Kaddu-Mulindwa, Dominic
Thurner, Lorenz
Bewarder, Moritz
Murawski, Niels
Ahlgrimm, Manfred
Pfuhl, Thorsten
Gärtner, Barbara
Smola, Sigrun
Stilgenbauer, Stephan
author_sort Kaddu-Mulindwa, Dominic
collection PubMed
description Due to the worldwide COVID-19 outbreak it is mandatory for health care workers to develop containment strategies. Recently published data showed, that cancer patients might have a higher risk for severe course of the disease. We therefore developed a strategy of screening and containment for SARS-CoV-2 for hospitalized cancer patients. Our approach includes a temporary isolation in a so-called floating zone and testing strategy for screening of asymptomatic individuals by pooling of samples before RT-PCR amplification. Patients as far as health care professionals got tested twice a week. Nurses and physicians entered the floating zone with full body protection. Within 8 weeks we tested 418 individuals (professionals and patients) in total. Only 2 patients had COVID-19 without documented further transmission of SARS-CoV-2. We therefore think that our strategy might be a useful approach to protect inpatients with cancer at high risk for SARS-CoV-2 infection during this ongoing pandemic.
format Online
Article
Text
id pubmed-7903402
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79034022021-02-24 Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls Kaddu-Mulindwa, Dominic Thurner, Lorenz Bewarder, Moritz Murawski, Niels Ahlgrimm, Manfred Pfuhl, Thorsten Gärtner, Barbara Smola, Sigrun Stilgenbauer, Stephan Infect Agent Cancer Letter to the Editor Due to the worldwide COVID-19 outbreak it is mandatory for health care workers to develop containment strategies. Recently published data showed, that cancer patients might have a higher risk for severe course of the disease. We therefore developed a strategy of screening and containment for SARS-CoV-2 for hospitalized cancer patients. Our approach includes a temporary isolation in a so-called floating zone and testing strategy for screening of asymptomatic individuals by pooling of samples before RT-PCR amplification. Patients as far as health care professionals got tested twice a week. Nurses and physicians entered the floating zone with full body protection. Within 8 weeks we tested 418 individuals (professionals and patients) in total. Only 2 patients had COVID-19 without documented further transmission of SARS-CoV-2. We therefore think that our strategy might be a useful approach to protect inpatients with cancer at high risk for SARS-CoV-2 infection during this ongoing pandemic. BioMed Central 2021-02-24 /pmc/articles/PMC7903402/ /pubmed/33627114 http://dx.doi.org/10.1186/s13027-021-00356-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Kaddu-Mulindwa, Dominic
Thurner, Lorenz
Bewarder, Moritz
Murawski, Niels
Ahlgrimm, Manfred
Pfuhl, Thorsten
Gärtner, Barbara
Smola, Sigrun
Stilgenbauer, Stephan
Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls
title Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls
title_full Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls
title_fullStr Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls
title_full_unstemmed Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls
title_short Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls
title_sort protection strategy against outbreak of covid-19 at a tertiary hematology-oncology: strengths and pitfalls
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903402/
https://www.ncbi.nlm.nih.gov/pubmed/33627114
http://dx.doi.org/10.1186/s13027-021-00356-5
work_keys_str_mv AT kaddumulindwadominic protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls
AT thurnerlorenz protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls
AT bewardermoritz protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls
AT murawskiniels protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls
AT ahlgrimmmanfred protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls
AT pfuhlthorsten protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls
AT gartnerbarbara protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls
AT smolasigrun protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls
AT stilgenbauerstephan protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls